CME Group (CME)
(Delayed Data from NSDQ)
$197.25 USD
-0.19 (-0.10%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $197.25 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$197.25 USD
-0.19 (-0.10%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $197.25 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
Formed in 2007 by the merger of the Chicago Mercantile Exchange (CME) and the Chicago Board of Trade (CBOT), CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. The Chicago Mercantile Exchange was originally formed as a non-profit organization in 1898, but was converted to a for-profit company in 2000. It became the first publicly traded financial exchange in the U.S. in Dec 2002. CBOT, established in 1848, is a leading futures and options exchange. In Apr 2005, CBOT converted into a for-profit stock-based holding company and for-profit membership exchange subsidiary.
CME Group (CME) Q2 Earnings Top on Record Trading Volume
by Zacks Equity Research
CME Group (CME) Q2 results reflect benefits of record trading volumes.
Here's What Key Metrics Tell Us About CME (CME) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for CME (CME) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
CME Group (CME) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 1.99% and 0.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is a Beat in the Offing for Nasdaq (NDAQ) in Q2 Earnings?
by Zacks Equity Research
Nasdaq's (NDAQ) second-quarter performance is likely to have been driven by organic revenue growth and strong Market Platforms businesses, data and listing service revenues, and Adenza contributions.
First Full Week of Q2 Earnings, PCE Out Friday
by Mark Vickery
No fewer than 845 companies are scheduled to report this week, including Alphabet (GOOGL) and Tesla (TSLA) Tuesday.
Is a Beat in the Cards for CME Group (CME) in Q2 Earnings?
by Zacks Equity Research
CME Group's (CME) second-quarter 2024 results are likely to reflect a diverse product portfolio, increased volatility, as well as a strong market position.
Nasdaq (NDAQ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain CME Group (CME) Stock Right Now
by Zacks Equity Research
CME Group (CME) stands to benefit from its global presence, compelling product portfolio and focus on over-the-counter clearing services and optimistic growth projections.
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME, Coinbase Global, Cboe Global Markets and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME, Coinbase Global, Cboe Global Markets and MarketAxess have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Prospering Securities and Exchanges Industry
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, COIN, CBOE and MKTX. However, compliance with regulations remains a challenge.
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
3 Crypto Stocks to Watch as Ethereum Rises on Regulatory Win
by Abhinab Dasgupta
HIVE Digital (HIVE), CME Group (CME) and BlackRock (BLK) are three Ethereum-exposed stocks that should be tracked as the Bitcoin rival wins a compliance battle with the SEC.
Here's Why Hold Strategy is Apt for CME Group (CME) Stock
by Zacks Equity Research
CME Group (CME) stands to benefit from its global presence, compelling product portfolio and focus on over-the-counter clearing services and optimistic growth projections.
Robinhood (HOOD) Stock Up 6.5% on $200M Bitstamp Buyout Deal
by Zacks Equity Research
Shares of Robinhood (HOOD) shoot up on confirmation that it was buying Bitstamp in a $200 million deal.
Top Stock Reports for NextEra Energy, BP & Gilead Sciences
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NextEra Energy, Inc. (NEE), BP p.l.c. (BP) and Gilead Sciences, Inc. (GILD), as well as two micro-cap stocks Hamilton Beach Brands Holding Company (HBB) and FONAR Corporation (FONR).
CME (CME) Down 0.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Top Stock Reports for UnitedHealth, Danaher & Abbott
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and Abbott Laboratories (ABT), as well as a micro-cap stock Ark Restaurants Corp. (ARKR).
Here's Why You Should Stay Invested in CME Group (CME) Stock
by Zacks Equity Research
CME Group's (CME) global presence, compelling product portfolio and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
Cboe Global (CBOE) Q1 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Cboe Global (CBOE) Q1 results reflect non-transaction revenue growth across market data fees, access and capacity fees, improved derivatives markets and data and access solutions net revenues.
Intercontinental (ICE) Q1 Earnings Meet Estimates, Revenues Lag
by Zacks Equity Research
Intercontinental (ICE) first-quarter results reflect the strength of a balanced and diversified business as well as the effects of the strategic investments it has made.
Nasdaq's (NDAQ) Q1 Earnings Miss, Revenues Top, Dividend Raised
by Zacks Equity Research
Nasdaq's (NDAQ) first-quarter results reflect lower Market Services net revenues and higher expenses. Listings, too, dropped in the reported quarter.
CME Group (CME) Q1 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
CME Group (CME) Q1 results reflect higher revenues and increased average daily volume in four of its six asset classes.
CME (CME) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for CME (CME) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.